• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Gynecological endocrinology: the official journal of the International Society of Gynecological Endocrinology >Use of hormone therapy for menopausal symptoms and quality of life in breast cancer survivors. Safe and ethical?
【24h】

Use of hormone therapy for menopausal symptoms and quality of life in breast cancer survivors. Safe and ethical?

机译：乳腺癌幸存者中使用激素治疗对更年期的症状和生活质量。 安全和道德？

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Breast cancer is the most prevalent cancer in women and presently, the breast cancer survivors are an important group of women that faced the several consequences of estrogen deficiency, which is especially common in women after chemotherapy. The most bothersome is the vasomotor symptoms, which are effectively relieved by hormonal therapy (HT). Also, the increased risk of osteoporosis and coronary artery disease is major problem to be resolved in pos of maintaining a good quality of life. Fearing cancer recurrence, most physicians do not offer HT to women with a history of breast cancer. Over this issue reviews the available evidence of the use of HT and tibolone in women treated for breast cancer.
机译：乳腺癌是女性中最普遍的癌症，目前，乳腺癌幸存者是一群重要的女性，面临雌激素缺乏的几个后果，在化疗后女性特别常见。 最麻烦的是血管运动症状，通过激素治疗（HT）有效缓解。 此外，骨质疏松症和冠状动脉疾病的风险增加是在维持良好生活质量的POS中得到解决的主要问题。 令人担忧的癌症复发，大多数医生不为患有乳腺癌的历史提供HT。 在这个问题上审查了对治疗乳腺癌的妇女使用HT和Tibolone的可用证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号